You searched for liver disease | Page 200 of 445

Proof Diagnostics Seeks Emergency Use Authorization of CRISPER-Based POC COVID Test

Proof Diagnostics announced the submission of its EUA request for review to the U.S. FDA for its POC molecular diagnostic test for COVID-19.

Cue Health is now offering its point-of-care solutions for BioReference’s clinical customers, including healthcare providers and POC clinics.

Posted by Andy Lundin | Apr 7, 2022 | Cancer |

Guardant Health partnered with Epic, a health record company, to integrate the oncology company’s portfolio of cancer tests with its services.

Helix received FDA Emergency Use Authorization for its SARS-CoV-2 Test and Helix COVID-19 Self-Collection Kit.

Visby will provide Urgent Care for Children with its Sexual Health Click Test for the detection of STIs in females 14 years of age and older.